시장보고서
상품코드
1487583

체외수정(IVF) 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향 및 예측(2024-2034년)

In Vitro Fertilization Market (Product: Equipment, Reagents & Media, and Accessories; and Type: Conventional IVF, IVF with ICSI, and IVF with Donor Eggs) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034

발행일: | 리서치사: Transparency Market Research | 페이지 정보: 영문 170 Pages | 배송안내 : 2-10일 (영업일 기준)

    
    
    


※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

체외수정(IVF) 시장 - 조사 범위

TMR의 세계 체외수정(IVF) 시장에 대한 조사 보고서는 2024년부터 2034년까지의 예측 기간 동안 시장 지표에 대한 귀중한 통찰력을 얻기 위해 과거뿐만 아니라 현재의 성장 동향과 기회를 조사했습니다. 이 보고서는 2024년을 기준연도로, 2034년을 예측 연도로 하여 2018년부터 2034년까지 전 세계 체외수정(IVF) 시장의 수익과 예측을 제공합니다. 또한 2024년부터 2034년까지 세계 체외수정(IVF) 시장의 연평균 성장률(CAGR%)도 제시합니다.

이 보고서는 광범위한 조사 끝에 작성되었으며, 1차 조사에서 분석가들은 KOL(Key Opinion Leader), 업계 리더 및 오피니언 제조업체를 인터뷰하고, 2차 조사에서는 IVF 시장을 이해하기 위해 주요 기업의 제품 자료, 연례 보고서, 보도 자료 및 관련 문서를 참조했습니다. 관련 문서를 참고했습니다.

시장 현황
2023년 시장 규모 7억 8,110만 달러
2034년 시장 가치 1.5억 달러
CAGR 6.2%

이 보고서는 세계 체외수정(IVF) 시장의 경쟁 환경에 대해 심층적으로 분석합니다. 세계 체외수정(IVF) 시장에서 사업을 운영하는 주요 기업들이 확인되었으며, 각 기업들은 다양한 속성으로 프로파일링되었습니다. 기업 개요, 재무 상태, 최근 동향 및 SWOT는 이 보고서에서 다루는 세계 체외수정(IVF) 시장 기업의 속성입니다.

목차

제1장 서문

제2장 전제조건과 조사 방법

제3장 주요 요약 : 세계 시장

제4장 시장 개요

  • 서론
  • 시장 개요
  • 시장 역학
  • 세계 시장 분석과 예측, 2020년-2034년

제5장 주요 인사이트

  • 파이프라인 분석
  • 주요 제품/브랜드 분석
  • 주요 M&A
  • COVID-19 팬데믹의 산업에 대한 영향

제6장 세계 시장 분석과 예측 : 제품별

  • 서론과 정의
  • 주요 조사 결과/발전
  • 시장 매출 예측 : 제품별, 2020년-2034년
    • 기기
    • 시약·배지
    • 액세서리
  • 시장의 매력 : 제품별

제7장 세계 시장 분석과 예측 : 사이클별

  • 서론과 정의
  • 주요 조사 결과/발전
  • 시장 매출 예측 : 사이클별, 2020년-2034년
    • 신선비 기증자 사이클
    • 동결비 기증자 IVF 사이클
    • 동결 기증자 IVF 사이클
    • 신선 기증자 IVF 사이클
  • 시장의 매력 : 사이클 별

제8장 세계 시장 분석과 예측 : 유형별

  • 서론과 정의
  • 주요 조사 결과/발전
  • 시장 매출 예측 : 유형별, 2020년-2034년
    • Conventional IVF
    • 현미수정에 의한 IVF
    • 기증자 난자에 의한 IVF
  • 시장의 매력 : 유형별

제9장 세계 시장 분석과 예측 : 최종사용자별

  • 서론과 정의
  • 주요 조사 결과/발전
  • 시장 매출 예측 : 최종사용자별, 2020년-2034년
    • 불임 치료 클리닉
    • 병원·수술센터
    • 쿠라이오반크&연구기관
  • 시장의 매력 : 최종사용자별

제10장 세계 시장 분석과 예측 : 지역별

  • 주요 조사 결과
  • 시장 매출 예측 : 지역별, 2020년-2034년
    • 북미
    • 유럽
    • 아시아태평양
    • 라틴아메리카
    • 중동 및 아프리카
  • 시장의 매력 : 지역별

제11장 북미 시장 분석과 예측

제12장 유럽 시장 분석과 예측

제13장 아시아태평양 시장 분석과 예측

제14장 라틴아메리카 시장 분석과 예측

제15장 중동 및 아프리카 시장 분석과 예측

제16장 경쟁 구도

  • 시장 경쟁 매트릭스(기업 Tier별, 기업 규모별)
  • 시장 점유율 분석 : 기업별(2023년)
  • 기업 개요
    • Vitrolife AB
    • Cook Medical
    • Thermo Fisher Scientific, Inc.
    • Merck KGAA
    • Ovascience, Inc.
    • CooperSurgical
    • Genea Ltd.
    • Rocket Medical PLC
    • Fertility Focus Ltd.
LSH 24.06.07

In Vitro Fertilization Market - Scope of Report

TMR's report on the global in vitro fertilization market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global in vitro fertilization market for the period 2018-2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global in vitro fertilization market from 2024 to 2034.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the in vitro fertilization market.

Market Snapshot
Market Value in 2023US$ 781.1 Mn
Market Value in 2034US$ 1.5 Bn
CAGR6.2%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global in vitro fertilization market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global in vitro fertilization market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global in vitro fertilization market.

The report delves into the competitive landscape of the global in vitro fertilization market. Key players operating in the global in vitro fertilization market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global in vitro fertilization market profiled in this report.

Key Questions Answered in Global in vitro fertilization Market Report:

  • What is the sales/revenue generated by in vitro fertilization across all regions during the forecast period?
  • What are the opportunities in the global in vitro fertilization market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2034?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

In Vitro Fertilization Market - Research Objectives and Research Approach

The comprehensive report on the global in vitro fertilization market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global in vitro fertilization market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global in vitro fertilization market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global In Vitro Fertilization Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Product Definition
    • 4.1.2. Industry Evolution / Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global In Vitro Fertilization Market Analysis and Forecast, 2020-2034

5. Key Insights

  • 5.1. Pipeline Analysis
  • 5.2. Key Product/Brand Analysis
  • 5.3. Key Mergers & Acquisitions
  • 5.4. COVID-19 Pandemic Impact on Industry

6. Global In Vitro Fertilization Market Analysis and Forecast, by Product

  • 6.1. Introduction and Definitions
  • 6.2. Key Findings/Developments
  • 6.3. Market Value Forecast, by Product, 2020-2034
    • 6.3.1. Equipment
    • 6.3.2. Reagents & Media
    • 6.3.3. Accessories
  • 6.4. Market Attractiveness, by Product

7. Global In Vitro Fertilization Market Analysis and Forecast, by Cycle

  • 7.1. Introduction and Definitions
  • 7.2. Key Findings/Developments
  • 7.3. Market Value Forecast, by Cycle, 2020-2034
    • 7.3.1. Fresh Non-donor Cycle
    • 7.3.2. Frozen Non-donor IVF Cycle
    • 7.3.3. Frozen donor IVF Cycle
    • 7.3.4. Fresh donor IVF Cycle
  • 7.4. Market Attractiveness, by Cycle

8. Global In Vitro Fertilization Market Analysis and Forecast, by Type

  • 8.1. Introduction and Definitions
  • 8.2. Key Findings/Developments
  • 8.3. Market Value Forecast, by Type, 2020-2034
    • 8.3.1. Conventional IVF
    • 8.3.2. IVF with ICSI
    • 8.3.3. IVF with Donor Eggs
  • 8.4. Market Attractiveness, by Type

9. Global In Vitro Fertilization Market Analysis and Forecast, by End-user

  • 9.1. Introduction and Definitions
  • 9.2. Key Findings/Developments
  • 9.3. Market Value Forecast, by End-user, 2020-2034
    • 9.3.1. Fertility Clinics
    • 9.3.2. Hospitals & Surgical Centers
    • 9.3.3. Cryobanks & Research Institutes
  • 9.4. Market Attractiveness, by End-user

10. Global In Vitro Fertilization Market Analysis and Forecast, by Region

  • 10.1. Key Findings
  • 10.2. Market Value Forecast, by Region, 2020-2034
    • 10.2.1. North America
    • 10.2.2. Europe
    • 10.2.3. Asia Pacific
    • 10.2.4. Latin America
    • 10.2.5. Middle East & Africa
  • 10.3. Market Attractiveness, by Region

11. North America In Vitro Fertilization Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Product, 2020-2034
    • 11.2.1. Equipment
    • 11.2.2. Reagents & Media
    • 11.2.3. Accessories
  • 11.3. Market Attractiveness, by Product
  • 11.4. Market Value Forecast, by Cycle, 2020-2034
    • 11.4.1. Fresh Non-donor Cycle
    • 11.4.2. Frozen Non-donor IVF Cycle
    • 11.4.3. Frozen donor IVF Cycle
    • 11.4.4. Fresh donor IVF Cycle
  • 11.5. Market Attractiveness, by Cycle
  • 11.6. Market Value Forecast, by Type, 2020-2034
    • 11.6.1. Conventional IVF
    • 11.6.2. IVF with ICSI
    • 11.6.3. IVF with Donor Eggs
  • 11.7. Market Attractiveness, by Type
  • 11.8. Market Value Forecast, by End-user, 2020-2034
    • 11.8.1. Fertility Clinics
    • 11.8.2. Hospitals & Surgical Centers
    • 11.8.3. Cryobanks & Research Institutes
  • 11.9. Market Attractiveness, by End-user
  • 11.10. Market Value Forecast, by Country/Sub-region, 2020-2034
    • 11.10.1. U.S.
    • 11.10.2. Canada
  • 11.11. Market Attractiveness Analysis
    • 11.11.1. By Product
    • 11.11.2. By Cycle
    • 11.11.3. By Type
    • 11.11.4. By End-user
    • 11.11.5. By Country

12. Europe In Vitro Fertilization Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Product, 2020-2034
    • 12.2.1. Equipment
    • 12.2.2. Reagents & Media
    • 12.2.3. Accessories
  • 12.3. Market Attractiveness, by Product
  • 12.4. Market Value Forecast, by Cycle, 2020-2034
    • 12.4.1. Fresh Non-donor Cycle
    • 12.4.2. Frozen Non-donor IVF Cycle
    • 12.4.3. Frozen donor IVF Cycle
    • 12.4.4. Fresh donor IVF Cycle
  • 12.5. Market Attractiveness, by Cycle
  • 12.6. Market Value Forecast, by Type, 2020-2034
    • 12.6.1. Conventional IVF
    • 12.6.2. IVF with ICSI
    • 12.6.3. IVF with Donor Eggs
  • 12.7. Market Attractiveness, by Type
  • 12.8. Market Value Forecast, by End-user, 2020-2034
    • 12.8.1. Fertility Clinics
    • 12.8.2. Hospitals & Surgical Centers
    • 12.8.3. Cryobanks & Research Institutes
  • 12.9. Market Attractiveness, by End-user
  • 12.10. Market Value Forecast, by Country/Sub-region, 2020-2034
    • 12.10.1. Germany
    • 12.10.2. U.K.
    • 12.10.3. France
    • 12.10.4. Italy
    • 12.10.5. Spain
    • 12.10.6. Rest of Europe
  • 12.11. Market Attractiveness Analysis
    • 12.11.1. By Product
    • 12.11.2. By Cycle
    • 12.11.3. By Type
    • 12.11.4. By End-user
    • 12.11.5. By Country/Sub-region

13. Asia Pacific In Vitro Fertilization Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Product, 2020-2034
    • 13.2.1. Equipment
    • 13.2.2. Reagents & Media
    • 13.2.3. Accessories
  • 13.3. Market Attractiveness, by Product
  • 13.4. Market Value Forecast, by Cycle, 2020-2034
    • 13.4.1. Fresh Non-donor Cycle
    • 13.4.2. Frozen Non-donor IVF Cycle
    • 13.4.3. Frozen donor IVF Cycle
    • 13.4.4. Fresh donor IVF Cycle
  • 13.5. Market Attractiveness, by Cycle
  • 13.6. Market Value Forecast, by Type, 2020-2034
    • 13.6.1. Conventional IVF
    • 13.6.2. IVF with ICSI
    • 13.6.3. IVF with Donor Eggs
  • 13.7. Market Attractiveness, by Type
  • 13.8. Market Value Forecast, by End-user, 2020-2034
    • 13.8.1. Fertility Clinics
    • 13.8.2. Hospitals & Surgical Centers
    • 13.8.3. Cryobanks & Research Institutes
  • 13.9. Market Attractiveness, by End-user
  • 13.10. Market Value Forecast, by Country/Sub-region, 2020-2034
    • 13.10.1. China
    • 13.10.2. Japan
    • 13.10.3. India
    • 13.10.4. Australia & New Zealand
    • 13.10.5. Rest of Asia Pacific
  • 13.11. Market Attractiveness Analysis
    • 13.11.1. By Product
    • 13.11.2. By Cycle
    • 13.11.3. By Type
    • 13.11.4. By End-user
    • 13.11.5. By Country/Sub-region

14. Latin America In Vitro Fertilization Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast, by Product, 2020-2034
    • 14.2.1. Equipment
    • 14.2.2. Reagents & Media
    • 14.2.3. Accessories
  • 14.3. Market Attractiveness, by Product
  • 14.4. Market Value Forecast, by Cycle, 2020-2034
    • 14.4.1. Fresh Non-donor Cycle
    • 14.4.2. Frozen Non-donor IVF Cycle
    • 14.4.3. Frozen donor IVF Cycle
    • 14.4.4. Fresh donor IVF Cycle
  • 14.5. Market Attractiveness, by Cycle
  • 14.6. Market Value Forecast, by Type, 2020-2034
    • 14.6.1. Conventional IVF
    • 14.6.2. IVF with ICSI
    • 14.6.3. IVF with Donor Eggs
  • 14.7. Market Attractiveness, by Type
  • 14.8. Market Value Forecast, by End-user, 2020-2034
    • 14.8.1. Fertility Clinics
    • 14.8.2. Hospitals & Surgical Centers
    • 14.8.3. Cryobanks & Research Institutes
  • 14.9. Market Attractiveness, by End-user
  • 14.10. Market Value Forecast, by Country/Sub-region, 2020-2034
    • 14.10.1. Brazil
    • 14.10.2. Mexico
    • 14.10.3. Rest of Latin America
  • 14.11. Market Attractiveness Analysis
    • 14.11.1. By Product
    • 14.11.2. By Cycle
    • 14.11.3. By Type
    • 14.11.4. By End-user
    • 14.11.5. By Country/Sub-region

15. Middle East & Africa In Vitro Fertilization Market Analysis and Forecast

  • 15.1. Introduction
    • 15.1.1. Key Findings
  • 15.2. Market Value Forecast, by Product, 2020-2034
    • 15.2.1. Equipment
    • 15.2.2. Reagents & Media
    • 15.2.3. Accessories
  • 15.3. Market Attractiveness, by Product
  • 15.4. Market Value Forecast, by Cycle, 2020-2034
    • 15.4.1. Fresh Non-donor Cycle
    • 15.4.2. Frozen Non-donor IVF Cycle
    • 15.4.3. Frozen donor IVF Cycle
    • 15.4.4. Fresh donor IVF Cycle
  • 15.5. Market Attractiveness, by Cycle
  • 15.6. Market Value Forecast, by Type, 2020-2034
    • 15.6.1. Conventional IVF
    • 15.6.2. IVF with ICSI
    • 15.6.3. IVF with Donor Eggs
  • 15.7. Market Attractiveness, by Type
  • 15.8. Market Value Forecast, by End-user, 2020-2034
    • 15.8.1. Fertility Clinics
    • 15.8.2. Hospitals & Surgical Centers
    • 15.8.3. Cryobanks & Research Institutes
  • 15.9. Market Attractiveness, by End-user
  • 15.10. Market Value Forecast, by Country/Sub-region, 2020-2034
    • 15.10.1. GCC Countries
    • 15.10.2. South Africa
    • 15.10.3. Rest of Middle East & Africa
  • 15.11. Market Attractiveness Analysis
    • 15.11.1. By Product
    • 15.11.2. By Cycle
    • 15.11.3. By Type
    • 15.11.4. By End-user
    • 15.11.5. By Country/Sub-region

16. Competition Landscape

  • 16.1. Market Player - Competition Matrix (By Tier and Size of Companies)
  • 16.2. Market Share Analysis, by Company (2023)
  • 16.3. Company Profiles
    • 16.3.1. Vitrolife AB
      • 16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.1.2. Product Portfolio
      • 16.3.1.3. Financial Overview
      • 16.3.1.4. SWOT Analysis
      • 16.3.1.5. Strategic Overview
    • 16.3.2. Cook Medical
      • 16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.2.2. Product Portfolio
      • 16.3.2.3. Financial Overview
      • 16.3.2.4. SWOT Analysis
      • 16.3.2.5. Strategic Overview
    • 16.3.3. Thermo Fisher Scientific, Inc.
      • 16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.3.2. Product Portfolio
      • 16.3.3.3. Financial Overview
      • 16.3.3.4. SWOT Analysis
      • 16.3.3.5. Strategic Overview
    • 16.3.4. Merck KGAA
      • 16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.4.2. Product Portfolio
      • 16.3.4.3. Financial Overview
      • 16.3.4.4. SWOT Analysis
      • 16.3.4.5. Strategic Overview
    • 16.3.5. Ovascience, Inc.
      • 16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.5.2. Product Portfolio
      • 16.3.5.3. Financial Overview
      • 16.3.5.4. SWOT Analysis
      • 16.3.5.5. Strategic Overview
    • 16.3.6. CooperSurgical
      • 16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.6.2. Product Portfolio
      • 16.3.6.3. Financial Overview
      • 16.3.6.4. SWOT Analysis
      • 16.3.6.5. Strategic Overview
    • 16.3.7. Genea Ltd.
      • 16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.7.2. Product Portfolio
      • 16.3.7.3. Financial Overview
      • 16.3.7.4. SWOT Analysis
      • 16.3.7.5. Strategic Overview
    • 16.3.8. Rocket Medical PLC
      • 16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.8.2. Product Portfolio
      • 16.3.8.3. Financial Overview
      • 16.3.8.4. SWOT Analysis
      • 16.3.8.5. Strategic Overview
    • 16.3.9. Fertility Focus Ltd.
      • 16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.9.2. Product Portfolio
      • 16.3.9.3. Financial Overview
      • 16.3.9.4. SWOT Analysis
      • 16.3.9.5. Strategic Overview
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제